0001193125-24-065858.txt : 20240312 0001193125-24-065858.hdr.sgml : 20240312 20240312160557 ACCESSION NUMBER: 0001193125-24-065858 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240308 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 24742089 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 8-K 1 d723839d8k.htm 8-K 8-K
false 0001756262 0001756262 2024-03-08 2024-03-08

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 8, 2024

 

 

TransMedics Group, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Massachusetts   001-38891   83-2181531

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

200 Minuteman Road

Andover, Massachusetts

   01810
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (978) 552-0900

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock, no par value per share   TMDX   The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 2.01.

Completion of Acquisition or Disposition of Assets.

As previously disclosed in a Current Report on Form 8-K filed by TransMedics Group, Inc. (the “Company”) on September 5, 2023, a Current Report on Form 8-K filed by the Company on September 12, 2023, a Current Report on Form 8-K filed by the Company on September 22, 2023, a Current Report on Form 8-K filed by the Company on November 13, 2023, a Current Report on Form 8-K filed by the Company on December 19, 2023, a Current Report on Form 8-K filed by the Company on January 2, 2024, a Current Report on Form 8-K filed by the Company on January 29, 2024, and a Current Report on Form 8-K filed by the Company on February 6, 2024 (together, the “Prior Reports”), TransMedics, Inc. (the “Buyer”), a Delaware corporation and wholly-owned subsidiary of the Company, acquired 13 fixed-wing aircraft (collectively, the “Prior Acquisitions”) as more specifically described in the Prior Reports.

Subsequently, on March 8, 2024, the Buyer acquired a fixed-wing aircraft from Evans General Aviation, LLC for a purchase price of approximately $12.5 million (together with the Prior Acquisitions, the “Acquisitions”). The Company intends to use each of the 14 aircraft it has acquired to date to transport donor organs as part of the services offered under the Company’s National OCS Program, and for purposes of this Current Report on Form 8-K the Company considers the Acquisitions to be a series of related transactions with respect to the acquisition of a fleet of aircraft for use in the Company’s National OCS Program.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      TRANSMEDICS GROUP, INC.
Date: March 12, 2024     By:  

/s/ Stephen Gordon

    Name:   Stephen Gordon
    Title:   Chief Financial Officer and Treasurer
 EX-101.SCH 2 tmdx-20240308.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 tmdx-20240308_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 tmdx-20240308_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information
Mar. 08, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001756262
Document Type 8-K
Document Period End Date Mar. 08, 2024
Entity Registrant Name TransMedics Group, Inc.
Entity Incorporation State Country Code MA
Entity File Number 001-38891
Entity Tax Identification Number 83-2181531
Entity Address, Address Line One 200 Minuteman Road
Entity Address, City or Town Andover
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01810
City Area Code (978)
Local Phone Number 552-0900
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, no par value per share
Trading Symbol TMDX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d723839d8k.htm tmdx-20240308.xsd tmdx-20240308_lab.xml tmdx-20240308_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d723839d8k.htm": { "nsprefix": "tmdx", "nsuri": "http://www.transmedics.com/20240308", "dts": { "inline": { "local": [ "d723839d8k.htm" ] }, "schema": { "local": [ "tmdx-20240308.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "tmdx-20240308_lab.xml" ] }, "presentationLink": { "local": [ "tmdx-20240308_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-03-08_to_2024-03-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d723839d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-03-08_to_2024-03-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d723839d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.transmedics.com//20240308/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001193125-24-065858-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-065858-xbrl.zip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end XML 15 d723839d8k_htm.xml IDEA: XBRL DOCUMENT 0001756262 2024-03-08 2024-03-08 false 0001756262 8-K 2024-03-08 TransMedics Group, Inc. MA 001-38891 83-2181531 200 Minuteman Road Andover MA 01810 (978) 552-0900 false false false false Common Stock, no par value per share TMDX NASDAQ false